Amit Sachdev
EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals. Based in Boston, Massachusetts.
- Rank
- 3095th of 14,644
- Companies held
- 1
- Largest holding
- VRTX, 100.0% of total
- Latest SEC filing
- Jul 21, 2026
What the $38.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals VRTX Common Stock | Directly | 66,512 | $519.60 | $34.6M | 89.8% | Form 4, Jul 21, 2026 |
| Vertex Pharmaceuticals VRTX Common Stock | Held in Trust | 6,637 | $519.60 | $3.4M | 9.0% | Form 4, Jul 21, 2026 |
| Vertex Pharmaceuticals VRTX Common Stock | Indirectly (see filing footnote) | 882 | $519.60 | $458K | 1.2% | Form 4, Jul 21, 2026 |
Share counts are the amounts Amit Sachdev reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Sold | VRTX | 1,846 | $486.35 | $898K | View |
| Feb 19, 2026 | Sold | VRTX | 2,730 | $465.05 | $1.3M | View |
| Feb 19, 2026 | Sold | VRTX | 4,237 | $471.43 | $2.0M | View |
| Feb 19, 2026 | Sold | VRTX | 920 | $463.91 | $427K | View |
| Feb 19, 2026 | Sold | VRTX | 1,848 | $465.80 | $861K | View |
| Feb 19, 2026 | Sold | VRTX | 10,263 | $467.75 | $4.8M | View |
| Feb 19, 2026 | Sold | VRTX | 19,662 | $468.57 | $9.2M | View |
| Feb 19, 2026 | Sold | VRTX | 7,241 | $469.61 | $3.4M | View |
| Feb 19, 2026 | Sold | VRTX | 11,712 | $470.54 | $5.5M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3092 | Gus Bergsma See remarks, Bentley Systems. Exton, PA | $38.5M |
| 3093 | John Thomas Ross President, CEO, Central Bancompany. Jefferson City, MO | $38.5M |
| 3094 | Robert Marion Robuck Director, Central Bancompany. Jefferson City, MO | $38.5M |
| 3095 | Amit Sachdev EVP Chief Patient & Ext Af Off, Vertex Pharmaceuticals. Boston, MA | $38.5M |
| 3096 | Michael D. Ohalleran Director, Ryan Specialty Holdings. Chicago, IL | $38.4M |
| 3097 | Mary T. Barra Chair & CEO, General Motors. Burbank, CA | $38.4M |
| 3098 | Alan J. Hyatt Director, Shore Bancshares. Easton, MD | $38.4M |
Other Vertex Pharmaceuticals insiders
All VRTX insiders- Reshma Kewalramani$44.9MCEO & President. #2748 overall
- Stuart A. Arbuckle$33.0MEVP, COO. #3310 overall
- Ourania Tatsis$27.8MEVP, Chief Reg. & Quality Off.. #4019 overall
- Bruce I. Sachs$20.3MDirector. #5142 overall
- Jeffrey M. Leiden$18.3MExecutive Chairman. #4640 overall
- David Altshuler$17.9MEVP, Chief Scientific Officer. #5642 overall
Questions
How much stock does Amit Sachdev own?
Amit Sachdev holds $38,466,508 in listed stock based on SEC filings and current prices, mostly Vertex Pharmaceuticals (VRTX). That ranks 3095th on the Stock Rich List.
Is this Amit Sachdev's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Amit Sachdev last buy or sell stock?
The most recent open-market trade on file is a sale of 1,846 VRTX shares on Feb 25, 2026 at $486.35.